|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 507 for Vhl

0.055s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Kurihara T
Year: 2011
Journal: J Cell Biol
Title: Astrocyte pVHL and HIF-α isoforms are required for embryonic-to-adult vascular transition in the eye.
Volume: 195
Issue: 4
Pages: 689-701
Publication
First Author: Liu R
Year: 2022
Journal: Nat Commun
Title: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection.
Volume: 13
Issue: 1
Pages: 5093
Publication
First Author: Cantley J
Year: 2009
Journal: J Clin Invest
Title: Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.
Volume: 119
Issue: 1
Pages: 125-35
Publication
First Author: Lange C
Year: 2011
Journal: Neurobiol Dis
Title: Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision.
Volume: 41
Issue: 1
Pages: 119-30
Publication
First Author: Park SK
Year: 2007
Journal: Int J Oncol
Title: von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
Volume: 30
Issue: 2
Pages: 341-8
Publication
First Author: Mans DA
Year: 2013
Journal: J Pathol
Title: Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Volume: 231
Issue: 1
Pages: 117-29
Publication
First Author: Kimura K
Year: 2008
Journal: Am J Physiol Renal Physiol
Title: Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.
Volume: 295
Issue: 4
Pages: F1023-9
Publication
First Author: Frew IJ
Year: 2008
Journal: Mol Cell Biol
Title: Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.
Volume: 28
Issue: 14
Pages: 4536-48
Publication
First Author: Pfander D
Year: 2004
Journal: Development
Title: Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development.
Volume: 131
Issue: 10
Pages: 2497-508
Publication
First Author: Wang Y
Year: 2007
Journal: J Clin Invest
Title: The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.
Volume: 117
Issue: 6
Pages: 1616-26
Publication
First Author: Bhagat TD
Year: 2017
Journal: J Biol Chem
Title: Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.
Volume: 292
Issue: 3
Pages: 837-846
Publication  
First Author: Torres-Capelli M
Year: 2016
Journal: Sci Rep
Title: Role Of Hif2α Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation.
Volume: 6
Pages: 25357
Publication
First Author: Hemberger M
Year: 1999
Journal: Hum Mol Genet
Title: Expression of the von Hippel-Lindau-binding protein-1 (Vbp1) in fetal and adult mouse tissues.
Volume: 8
Issue: 2
Pages: 229-36
Publication  
First Author: Lepoutre-Lussey C
Year: 2016
Journal: Mol Cell Endocrinol
Title: From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma.
Volume: 421
Pages: 40-8
Publication
First Author: Mangiavini L
Year: 2015
Journal: Am J Pathol
Title: Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
Volume: 185
Issue: 11
Pages: 3090-101
Publication
First Author: Tang N
Year: 2006
Journal: Mol Cell Biol
Title: pVHL function is essential for endothelial extracellular matrix deposition.
Volume: 26
Issue: 7
Pages: 2519-30
Publication  
First Author: Gardner PJ
Year: 2017
Journal: Sci Rep
Title: Hypoxia inducible factors are dispensable for myeloid cell migration into the inflamed mouse eye.
Volume: 7
Pages: 40830
Publication  
First Author: Wei R
Year: 2019
Journal: JCI Insight
Title: Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma.
Volume: 4
Issue: 22
Publication
First Author: Myszczyszyn A
Year: 2024
Journal: PLoS One
Title: Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors.
Volume: 19
Issue: 3
Pages: e0282938
Publication
First Author: Gerl K
Year: 2015
Journal: Kidney Int
Title: Inducible glomerular erythropoietin production in the adult kidney.
Volume: 88
Issue: 6
Pages: 1345-1355
Publication
First Author: Rankin EB
Year: 2006
Journal: Cancer Res
Title: Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
Volume: 66
Issue: 5
Pages: 2576-83
Publication
First Author: Steenhard BM
Year: 2010
Journal: Am J Pathol
Title: Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.
Volume: 177
Issue: 1
Pages: 84-96
Publication
First Author: Todd VM
Year: 2021
Journal: Commun Biol
Title: Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner.
Volume: 4
Issue: 1
Pages: 1122
Publication
First Author: Hickey MM
Year: 2010
Journal: J Clin Invest
Title: The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice.
Volume: 120
Issue: 3
Pages: 827-39
Publication
First Author: Kantari-Mimoun C
Year: 2017
Journal: Oncotarget
Title: Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in mice.
Volume: 8
Issue: 9
Pages: 15085-15100
Publication
First Author: Zhang LF
Year: 2014
Journal: PLoS One
Title: Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway.
Volume: 9
Issue: 6
Pages: e99946
Publication
First Author: Giles RH
Year: 2006
Journal: Oncogene
Title: Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Volume: 25
Issue: 21
Pages: 3065-70
Publication  
First Author: Schori C
Year: 2019
Journal: Exp Eye Res
Title: A chronic hypoxic response in photoreceptors alters the vitreous proteome in mice.
Volume: 185
Pages: 107690
Publication
First Author: Hoefflin R
Year: 2020
Journal: Nat Commun
Title: HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.
Volume: 11
Issue: 1
Pages: 4111
Publication
First Author: Rankin EB
Year: 2005
Journal: Mol Cell Biol
Title: Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
Volume: 25
Issue: 8
Pages: 3163-72
Publication
First Author: Shah YM
Year: 2008
Journal: Gastroenterology
Title: Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.
Volume: 134
Issue: 7
Pages: 2036-48, 2048.e1-3
Publication
First Author: Lange C
Year: 2011
Journal: Invest Ophthalmol Vis Sci
Title: Normoxic activation of hypoxia-inducible factors in photoreceptors provides transient protection against light-induced retinal degeneration.
Volume: 52
Issue: 8
Pages: 5872-80
Publication
First Author: Schönenberger D
Year: 2016
Journal: Cancer Res
Title: Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
Volume: 76
Issue: 7
Pages: 2025-36
Publication
First Author: Zhang J
Year: 2012
Journal: Clin Exp Pharmacol Physiol
Title: Hypoxia-inducible factor 1 activation from adipose protein 2-cre mediated knockout of von Hippel-Lindau gene leads to embryonic lethality.
Volume: 39
Issue: 2
Pages: 145-50
Publication
First Author: Lei L
Year: 2008
Journal: Mol Cell Biol
Title: Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein.
Volume: 28
Issue: 11
Pages: 3790-803
Publication
First Author: Xue X
Year: 2012
Journal: Cancer Res
Title: Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.
Volume: 72
Issue: 9
Pages: 2285-93
Publication
First Author: Mekhail K
Year: 2005
Journal: J Cell Biol
Title: Regulation of ubiquitin ligase dynamics by the nucleolus.
Volume: 170
Issue: 5
Pages: 733-44
Publication
First Author: Menendez-Montes I
Year: 2016
Journal: Dev Cell
Title: Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation.
Volume: 39
Issue: 6
Pages: 724-739
Publication
First Author: Guinot A
Year: 2016
Journal: J Pathol
Title: Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
Volume: 239
Issue: 3
Pages: 365-73
Publication
First Author: Barben M
Year: 2018
Journal: Mol Neurodegener
Title: Targeting Hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia.
Volume: 13
Issue: 1
Pages: 12
Publication
First Author: Kamura T
Year: 2004
Journal: Genes Dev
Title: VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Volume: 18
Issue: 24
Pages: 3055-65
Publication
First Author: Kurihara T
Year: 2010
Journal: Development
Title: von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina.
Volume: 137
Issue: 9
Pages: 1563-71
Publication
First Author: Soggia A
Year: 2014
Journal: Diabetologia
Title: von Hippel-Lindau gene disruption in mouse pancreatic progenitors and its consequences on endocrine differentiation in vivo: importance of HIF1-α and VEGF-A upregulation.
Volume: 57
Issue: 11
Pages: 2348-56
Publication
First Author: Cargill K
Year: 2019
Journal: J Am Soc Nephrol
Title: Von Hippel-Lindau Acts as a Metabolic Switch Controlling Nephron Progenitor Differentiation.
Volume: 30
Issue: 7
Pages: 1192-1205
Publication
First Author: Gerl K
Year: 2017
Journal: Am J Pathol
Title: Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development.
Volume: 187
Issue: 7
Pages: 1496-1511
Publication
First Author: Lange CA
Year: 2012
Journal: Development
Title: Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development.
Volume: 139
Issue: 13
Pages: 2340-50
Publication  
First Author: Eberhart T
Year: 2020
Journal: Front Cell Dev Biol
Title: Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression.
Volume: 8
Pages: 566
Protein Domain
Type: Homologous_superfamily
Description: von Hippel-Landau (pVHL) protein, the gene product of VHL, is a critical regulator of the ubiquitous oxygen-sensing pathway. It is conserved throughout evolution, as its homologs are found in organisms ranging from mammals to Drosophila and Caenorhabditis. pVHL acts as the substrate recognition component of an E3 ubiquitin ligase complex. Several proteins have been identified as pVHL-binding proteins that are subject to ubiquitin-mediated proteolysis; the best characterized putative substrates are the alpha subunits of the hypoxia-inducible factor (HIF1alpha, HIF2alpha, and HIF3alpha). In addition to HIF degradation, pVHL has been implicated to be involved in HIF independent cellular processes. Germline VHL mutations cause renal cell carcinomas, hemangioblastomas and pheochromocytomas in humans. pVHL can bind to and direct the proper deposition of fibronectin and collagen IV within the extracellular matrix. It works to stabilize microtubules and foster the maintenance of primary cilium. It also has been reported to promote the stabilization and activation of p53 in a HIF-independent manner and, in neuronal cells, promote apoptosis by down-regulation of Jun-B [, , , , , , , , , , , , , ,, , , , , ].Von Hippel-Lindau disease tumor suppressor (VHL) has two domains: a roughly 100-residue N-terminal domain rich in beta sheet (beta domain) and a smaller α-helical domain (alpha domain), held together by two linkers and a polar interface. A large portion of the alpha domain surface, and a small portion of the beta domain, interact with ElonginC. About half of the tumorigenic mutations map to the alpha domain and its residues that contact ElonginC. The remaining mutations map to the beta domain, and significantly, to a beta domain surface patch uninvolved in ElonginC binding. This suggests that two intact macromolecular binding sites may be required for the tumor suppressor effects of VHL [].
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Neary MT
Year: 2013
Journal: Dis Model Mech
Title: A mouse model to study the link between hypoxia, long QT interval and sudden infant death syndrome.
Volume: 6
Issue: 2
Pages: 503-7
Publication
First Author: Nguyen TN
Year: 2022
Journal: Cancer Res
Title: IL6 and CCL18 Mediate Cross-talk between VHL-Deficient Kidney Cells and Macrophages during Development of Renal Cell Carcinoma.
Volume: 82
Issue: 15
Pages: 2716-2733
Publication
First Author: Zhou Q
Year: 2016
Journal: Am J Respir Cell Mol Biol
Title: Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.
Volume: 54
Issue: 5
Pages: 728-39
Publication
First Author: Slingo M
Year: 2016
Journal: Am J Physiol Heart Circ Physiol
Title: The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism.
Volume: 311
Issue: 3
Pages: H759-67
Publication
First Author: Chan SY
Year: 2009
Journal: Cell Metab
Title: MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.
Volume: 10
Issue: 4
Pages: 273-84
Publication  
First Author: Chen K
Year: 2021
Journal: Front Cell Dev Biol
Title: Osteocytic HIF-1α Pathway Manipulates Bone Micro-structure and Remodeling via Regulating Osteocyte Terminal Differentiation.
Volume: 9
Pages: 721561
Publication
First Author: White K
Year: 2015
Journal: EMBO Mol Med
Title: Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.
Volume: 7
Issue: 6
Pages: 695-713
Publication
First Author: Thorner PS
Year: 2008
Journal: J Am Soc Nephrol
Title: Podocytes contribute to the formation of glomerular crescents.
Volume: 19
Issue: 3
Pages: 495-502
Publication
First Author: Gnarra JR
Year: 1996
Journal: Biochim Biophys Acta
Title: Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
Volume: 1242
Issue: 3
Pages: 201-10
Publication
First Author: Kaelin WG Jr
Year: 1999
Journal: Nature
Title: Cancer. Many vessels, faulty gene.
Volume: 399
Issue: 6733
Pages: 203-4
Publication
First Author: Sinha S
Year: 2011
Journal: J Cell Sci
Title: Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.
Volume: 124
Issue: Pt 13
Pages: 2132-42
GXD Expression      
Probe: MGI:6444444
Assay Type: RT-PCR
Annotation Date: 2020-07-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1716828
Stage: TS28
Assay Id: MGI:6446189
Age: postnatal week 5
Specimen Label: wild type control
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:6444444
Assay Type: RT-PCR
Annotation Date: 2020-07-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1716828
Stage: TS28
Assay Id: MGI:6446189
Age: postnatal week 5
Specimen Label: miR-183C
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Vhlfl/fl
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Vhlfl/fl
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Vhlfl/fl
Detected: true
Specimen Num: 3
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/wt
Detected: true
Specimen Num: 4
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/wt
Detected: true
Specimen Num: 5
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/wt
Detected: true
Specimen Num: 6
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/fl
Detected: true
Specimen Num: 7
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/fl
Detected: true
Specimen Num: 8
GXD Expression      
Probe: MGI:7492316
Assay Type: Western blot
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750326
Stage: TS26
Assay Id: MGI:7492360
Age: embryonic day 18.5
Specimen Label: Sox9-Cre;Vhlfl/fl
Detected: true
Specimen Num: 9
GXD Expression      
Probe: MGI:7492318
Assay Type: RT-PCR
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750322
Stage: TS22
Assay Id: MGI:7492372
Age: embryonic day 14.5
Specimen Label: control
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:7492318
Assay Type: RT-PCR
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750322
Stage: TS22
Assay Id: MGI:7492372
Age: embryonic day 14.5
Specimen Label: Sox9-Cre
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:7492318
Assay Type: RT-PCR
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750325
Stage: TS25
Assay Id: MGI:7492399
Age: embryonic day 17.5
Specimen Label: Vhlfl/wt
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:7492318
Assay Type: RT-PCR
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750325
Stage: TS25
Assay Id: MGI:7492399
Age: embryonic day 17.5
Specimen Label: Sox9-Cre;Vhlfl/wt
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:7492318
Assay Type: RT-PCR
Annotation Date: 2023-06-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750325
Stage: TS25
Assay Id: MGI:7492399
Age: embryonic day 17.5
Specimen Label: Sox9-CreVhlfl/fl
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1665821
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:3807494
Age: embryonic day 13.5
Specimen Label: 1J
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1716124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3807494
Age: embryonic day 16.5
Specimen Label: 3N
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3807494
Age: embryonic day 16.5
Note: Expression is present in the neuroepithlium.
Specimen Label: 3F
Detected: true
Specimen Num: 12
GXD Expression    
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1876724
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3807494
Age: embryonic day 16.5
Specimen Label: 2D
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1737324
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3807494
Age: embryonic day 16.5
Specimen Label: 2D
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:3807493
Assay Type: RNA in situ
Annotation Date: 2008-09-24
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1737321
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:3807494
Age: embryonic day 13.5
Specimen Label: 1J
Detected: true
Specimen Num: 5